Top Markets
Coin of the day
Nanjing Hicin Pharmaceutical Co., Ltd. Nanjing Hicin Pharmaceutical Co., Ltd.

Nanjing Hicin Pharmaceutical Co., Ltd.

300584
Classificação em ações #12879
Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and... Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and headquartered in Nanjing, China, operates as a comprehensive enterprise specializing in the research, development, production, marketing, and distribution of pharmaceutical preparations and synthetic chemicals within China. The company boasts a diverse product portfolio, addressing various therapeutic areas such as antivirals, antibiotics, endocrine regulators, gastrointestinal treatments, orthopedic medications, cardiovascular and cerebrovascular drugs, and immunomodulatory agents. Beyond its core pharmaceutical activities, NHPC also provides technology transfer services. On an international scale, Nanjing Hicin Pharmaceutical Co., Ltd. is a supplier of Active Pharmaceutical Ingredients (APIs). Its export offerings specifically include injectable forms of omeprazole sodium and cefepime hydrochloride, along with lansoprazole tablets, which reach markets across South Asia, South America, and Europe.
Preço da ação
$4.51
Valor de mercado
$540.82M
Variação (1 dia)
-2.42%
Variação (1 ano)
-43.50%
País
CN
Negociar Nanjing Hicin Pharmaceutical Co., Ltd. (300584)

Categoria

Histórico de rendimento de dividendos para Nanjing Hicin Pharmaceutical Co., Ltd. (300584)
O rendimento de dividendos (TTM) da Nanjing Hicin Pharmaceutical Co., Ltd. (símbolo da ação: 300584) em 2026 é: 0
Rendimento médio dos dividendos nos últimos 5 anos: 0.00%
Histórico de rendimento de dividendos para Nanjing Hicin Pharmaceutical Co., Ltd. (300584) de 2026 a 2026
Rendimento de dividendos no final de cada ano (TTM)
Ano Rendimento de Dividendos Alterar
Não há dados suficientes para as datas fornecidas.
Rendimentos de dividendos (TTM) para empresas semelhantes ou concorrentes